Clinical Trials Directory

Trials / Completed

CompletedNCT05292378

Carbon Dioxide (CO2) and Cognitive Impairment

Carbon Dioxide (CO2): A Pilot Study of a Hypothesized Mechanism to Explain Cognitive Impairment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to better understand the biological mechanisms of carbon dioxide (CO2)-induced cognitive impairments.

Detailed description

Participants will complete 2 study visits. Each study visit will consist of a 2.5-hour exposure session. Concentrations of CO2 during the exposure session will be either 600 ppm (control) or 2500 ppm (exposure). The order of the exposure sessions will be randomized and the exposure sessions will be at least one week apart. Up to two participants will take part in each exposure session. During each exposure a neurobehavioral assessment (Strategic Management Simulations or SMS) will be administered. Venous blood (30 mL) will be collected from subjects immediately before entering the chamber and immediately after the exposure. A subset of subjects (n=12) will also undergo a 60-minute fMRI scan. Another subset of subjects (up to 10) will not complete the SMS during the exposures but will undergo computer-assisted intravital microscopy (CAIM) to exam the conjunctival microvasculature before and after the exposure.

Conditions

Interventions

TypeNameDescription
OTHER2500 ppm Carbon Dioxide2.5 hour exposure to 2500 ppm carbon dioxide
OTHER600 ppm Carbon Dioxide2.5 hour exposure to 600 ppm carbon dioxide

Timeline

Start date
2022-07-14
Primary completion
2025-03-20
Completion
2025-03-20
First posted
2022-03-23
Last updated
2026-03-16
Results posted
2026-03-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05292378. Inclusion in this directory is not an endorsement.